Bond CitiCorp 10% ( US1730T0A821 ) in USD

Issuer CitiCorp
Market price refresh price now   85.097 %  ▲ 
Country  United States
ISIN code  US1730T0A821 ( in USD )
Interest rate 10% per year ( payment 2 times a year)
Maturity 15/11/2028



Prospectus brochure in PDF format is unavailable at this time
We will provide it as soon as possible

Minimal amount 1 000 USD
Total amount 38 456 000 USD
Cusip 1730T0A82
Standard & Poor's ( S&P ) rating BBB+ ( Lower medium grade - Investment-grade )
Moody's rating NR
Next Coupon 15/11/2025 ( In 105 days )
Detailed description Citigroup is a multinational investment bank and financial services corporation providing a wide range of financial products and services, including consumer banking, corporate and investment banking, securities brokerage, and asset management, across numerous global markets.

This financial analysis focuses on a specific fixed-income instrument issued by Citigroup, a globally diversified financial services holding company incorporated in the United States and one of the world's largest banking organizations, providing consumers, corporations, governments, and institutions with a broad range of financial products and services. The bond, identified by ISIN US1730T0A821 and CUSIP 1730T0A82, is a USD-denominated obligation set to mature on November 15, 2028. It carries a substantial fixed annual coupon rate of 10%, with interest payments distributed semi-annually, reflecting its payment frequency of two per year. The total original issue size for this particular series stands at $38,456,000, with a minimum purchase increment established at $1,000. Currently, on the secondary market, this bond is quoted at a price of 85.097% of par, indicating it trades at a significant discount, which suggests a yield-to-maturity notably higher than its nominal coupon rate, potentially attracting investors seeking enhanced returns. Regarding its credit quality, the bond holds an investment-grade rating of BBB+ from Standard & Poor's, signaling a reasonable capacity for repayment, although it is not rated by Moody's, as indicated by 'NR'.